Pacific Biosciences's market cap is currently $512.12M. The company's EPS TTM is $-1.137; its P/E ratio is ―; Pacific Biosciences is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 200.52M	$ 128.30M	$ 130.51M	$ 78.89M	$ 90.89M
Gross Profit	$ 52.78M	$ 49.03M	$ 58.86M	$ 32.57M	$ 34.58M
Operating Income	$ -334.47M	$ -304.82M	$ -178.16M	$ -104.39M	$ -100.55M
EBITDA	$ -277.28M	$ -282.24M	$ -250.76M	$ 38.97M	$ -71.58M
Net Income	$ -306.74M	$ -296.93M	$ -181.22M	$ 29.40M	$ -77.82M
Balance Sheet
Cash & Short-Term Investments	$ 631.42M	$ 772.32M	$ 1.04B	$ 318.81M	$ 49.10M
Total Assets	$ 1.75B	$ 1.77B	$ 2.01B	$ 413.98M	$ 147.99M
Total Debt	$ 933.93M	$ 957.37M	$ 953.75M	$ 42.00M	$ 61.67M
Net Debt	$ 754.02M	$ 632.28M	$ 493.02M	$ -276.81M	$ 12.57M
Total Liabilities	$ 1.04B	$ 1.20B	$ 1.22B	$ 78.49M	$ 93.07M
Stockholders' Equity	$ 701.30M	$ 562.90M	$ 790.99M	$ 335.49M	$ 54.92M
Cash Flow
Free Cash Flow	$ -268.02M	$ -280.14M	$ -117.11M	$ 18.46M	$ -81.15M
Operating Cash Flow	$ -259.17M	$ -263.21M	$ -111.18M	$ 19.50M	$ -78.31M
Investing Cash Flow	$ 4.60M	$ 116.08M	$ -678.53M	$ -219.32M	$ 62.05M
Financing Cash Flow	$ 108.89M	$ 9.62M	$ 1.17B	$ 251.84M	$ 26.55M

Currency in USD

Pacific Biosciences Earnings and Revenue History

Income Statement >

Pacific Biosciences Debt to Assets

Balance Sheet >

Pacific Biosciences Cash Flow

Cash Flow >

Pacific Biosciences Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing